124,383 Shares in DocGo Inc. (NASDAQ:DCGO) Bought by Raymond James Financial Inc.

Raymond James Financial Inc. acquired a new stake in shares of DocGo Inc. (NASDAQ:DCGO - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 124,383 shares of the company's stock, valued at approximately $527,000. Raymond James Financial Inc. owned approximately 0.12% of DocGo as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. SG Americas Securities LLC boosted its stake in shares of DocGo by 12.9% during the 4th quarter. SG Americas Securities LLC now owns 43,052 shares of the company's stock worth $183,000 after purchasing an additional 4,905 shares during the period. Rhumbline Advisers lifted its stake in DocGo by 4.5% in the fourth quarter. Rhumbline Advisers now owns 142,762 shares of the company's stock worth $605,000 after purchasing an additional 6,204 shares during the last quarter. Victory Capital Management Inc. boosted its position in shares of DocGo by 12.3% during the fourth quarter. Victory Capital Management Inc. now owns 57,649 shares of the company's stock valued at $244,000 after buying an additional 6,300 shares during the period. Centiva Capital LP bought a new position in shares of DocGo during the third quarter valued at approximately $43,000. Finally, Intech Investment Management LLC purchased a new stake in shares of DocGo in the third quarter worth approximately $62,000. 56.44% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages have commented on DCGO. Needham & Company LLC reaffirmed a "buy" rating and issued a $4.00 price objective on shares of DocGo in a research report on Tuesday. Stifel Nicolaus decreased their price objective on shares of DocGo from $6.50 to $5.50 and set a "buy" rating for the company in a report on Friday, February 28th. Finally, Deutsche Bank Aktiengesellschaft cut shares of DocGo from a "buy" rating to a "hold" rating and lowered their price objective for the company from $5.00 to $2.85 in a research report on Friday, February 28th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $4.89.

DocGo Stock Performance

DocGo stock traded down $0.11 during midday trading on Friday, hitting $2.39. 1,063,222 shares of the company's stock were exchanged, compared to its average volume of 751,286. The company has a market cap of $243.74 million, a PE ratio of 8.54, a P/E/G ratio of 14.16 and a beta of 1.12. The firm has a 50-day moving average of $3.53 and a two-hundred day moving average of $3.83. DocGo Inc. has a 12 month low of $2.32 and a 12 month high of $5.68.

DocGo Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.